Qiagen NV | QIA - 债务利息支出

金融业

USD

USD 5.89B

现金及等价物

USD 646.29M

USD 196.45M

USD 1.66B

USD 581.45M

USD 1.65B

股息收益率

USD 0.9

USD 141.4M

USD 207.66M

USD 6.18K

EPS每股收益

USD 0.54

股本和储备

USD 3.36B

USD 340.39M

债务利息支出

USD 10.02M

USD 10.56M

USD 1.63B

USD 8.31B

USD 103.4M

USD 393.64M

USD 141.4M

普通股股本

USD 206.5M

16.72

USD 157.91M

USD 463.12M

销售和管理费用

USD 142.33M

USD 309.61M

贸易债权人

USD 79.08M

应收帐款人

USD 398.35M

	债务利息支出	更改		日
Akebia Therapeutics	349.66M		12.86M	2026-06
Alaunos Therapeutics	USD 1.07M		215K	2023-06
argenx SE	USD 1000K		172K	2026-03
Avita Medical	AUD 1.25M		100K	2025-06
Dianthus Therapeutics	USD 4.44M		263K	2024-09
Ionis Pharmaceuticals	USD 18M		1000K	2026-06
IQVIA Holdings	USD 197M		5M	2026-06
Moderna	USD 10.96B		527M	2026-06
Organon & Co	USD 108M		3M	2026-06
Qiagen NV	USD 10.02M		1.03M	2026-06
Revvity	USD 22.99M		1.73M	2026-06
Tectonic Therapeutic	USD 246.58M		246.56M	2026-03
Viatris	USD 120.7M		600K	2026-06
Xeris Pharmaceuticals	USD 6.88M		269K	2026-03